ARCT
Arcturus Therapeutics Holdings Inc.
NASDAQ · Healthcare · Biotechnology · US
$15.82
+1.67%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 26.15x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.62x
- Price / sales
- 18.89x
- Price / cash flow
- -6.18x
Enterprise value
- Enterprise value
- $281.1M
- EV / sales
- 11.81x
- EV / EBITDA
- -3.39x
- EV / EBIT
- -2.73x
- Market cap
- $449.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026